Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Experts argue about dementia detection in primary care practice at AFA-ADDF meeting

Experts argue about dementia detection in primary care practice at AFA-ADDF meeting

GE Healthcare's MIND campaign goes online for patients with neurodegenerative diseases

GE Healthcare's MIND campaign goes online for patients with neurodegenerative diseases

Decision support tool for objective diagnostics of Alzheimer's

Decision support tool for objective diagnostics of Alzheimer's

New drug candidate may halt mental decline of Alzheimer's

New drug candidate may halt mental decline of Alzheimer's

Magnetic stimulation of brain nerve cells may speed up recovery from hemispatial neglect

Magnetic stimulation of brain nerve cells may speed up recovery from hemispatial neglect

Antioxidant can delay onset of all indicators of Alzheimer's

Antioxidant can delay onset of all indicators of Alzheimer's

Molecular signature indicative of hypoxia predicts progression to AD

Molecular signature indicative of hypoxia predicts progression to AD

H2S plays critical role in signaling pathway linked to Alzheimer's and Parkinson's

H2S plays critical role in signaling pathway linked to Alzheimer's and Parkinson's

Acetylcholine can weaken synaptic connections between neurons in brain

Acetylcholine can weaken synaptic connections between neurons in brain

Link between high tau levels and worse outcome after head trauma

Link between high tau levels and worse outcome after head trauma

GW scientist to identify molecular mechanisms that define embryonic OE stem cells

GW scientist to identify molecular mechanisms that define embryonic OE stem cells

Brain atrophy is evident in Parkinson's patients with MCI

Brain atrophy is evident in Parkinson's patients with MCI

Intertwined diseases may both contribute to cognitive decline in Parkinson's

Intertwined diseases may both contribute to cognitive decline in Parkinson's

Study describes new method that synthesizes novel anti-HIV protein

Study describes new method that synthesizes novel anti-HIV protein

Roundup: Iowans question Wellmark premium hikes; Fla. Medicare audit; Mich. nursing home scandals

Roundup: Iowans question Wellmark premium hikes; Fla. Medicare audit; Mich. nursing home scandals

Alzheimer’s disease vaccine developed by Australian scientists

Alzheimer’s disease vaccine developed by Australian scientists

New method to design Alzheimer's antibodies

New method to design Alzheimer's antibodies

Tips to help ease caregiver's burden during holiday season

Tips to help ease caregiver's burden during holiday season

Pending budget cuts could jeopardize health, safety of state's most vulnerable seniors

Pending budget cuts could jeopardize health, safety of state's most vulnerable seniors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.